For most people living with heart failure, a combination of medications, regular monitoring, and careful lifestyle management keeps things stable. But there comes a point for some patients where the heart simply cannot keep up anymore — no matter what is prescribed or adjusted. Doctors call this Stage D, or end-stage heart failure, and it marks a turning point that changes every conversation about treatment.
Dr. Vishal Khullar, as an experienced Cardiac Surgeon in Mumbai, trained at Mayo Clinic and Cleveland Clinic, and now currently the Director of heart and lung transplant program at Fortis Mulund, has been part of over 300 heart and lung transplant procedures across India and the United States. This blog draws on that experience to explain when an LVAD or a heart transplant genuinely becomes necessary, and how that decision gets made in real clinical practice.
Most patients and families are familiar with the idea that heart failure gets worse over time. What is less understood is what it looks like when it reaches the final stage.
At Stage D, the heart is so weakened that it cannot pump enough blood to meet the body’s basic needs, even at rest. Medications that once helped have stopped making a meaningful difference.
Once a patient reaches this stage, the goal of treatment changes. It is no longer about managing symptoms. It is about keeping the person alive.
If your cardiologist has said that medications are no longer working the way they should, that conversation deserves a second opinion from a specialist. Speak with Dr. Vishal Khullar.
An LVAD, or Left Ventricular Assist Device, is a mechanical pump that is surgically placed inside the chest to help the heart pump blood when it can no longer do so adequately on its own. It is not a temporary fix. For many patients, it is a life-changing intervention.
Read more about LVAD surgery and what the procedure involves.
Some patients are eligible for a heart transplant but are too sick to survive the waiting period. An LVAD stabilises them, protects the kidneys and other organs from the effects of low blood flow, and buys the time they need until a donor heart becomes available.
Not every patient is a transplant candidate. Age, other health conditions, or personal circumstances may make a transplant unsuitable. In these cases, the LVAD is not a bridge to anything. It becomes the definitive, long-term treatment itself. Surgeons call this destination therapy.
A heart transplant is considered the most definitive treatment for end-stage heart failure. The failing heart is replaced with a healthy donor heart, giving the patient a genuine second chance. But it is a major undertaking, and not everyone qualifies.
Every MCS decision is unique. Get an expert opinion from Dr. Vishal Khullar.
This is what families want to know and rarely get a straight answer on. When the heart fails severely, every organ in the body begins to suffer because it is not receiving enough oxygenated blood. The kidneys struggle. The liver is under strain. The patient feels exhausted, breathless, and often confused about why they feel so unwell even when they are not in obvious pain.One of the most important things mechanical circulatory support does is begin to reverse that process.
This organ recovery is not just about how the patient feels day to day. It is clinically critical. A patient whose kidneys and liver have had time to recover during the bridging period is significantly more likely to survive transplant surgery and recover well from it than a patient whose organs were already damaged at the point of transplant.
This is rarely a straightforward either-or decision. It depends on the patient’s full clinical picture, their age, how other organs are functioning, whether they qualify for transplant listing, and often their personal wishes too.
The decision between an LVAD and a transplant is one of the most important a cardiac patient and their family will ever face. Book a consultation with Dr. Vishal Khullar to understand which path makes sense for your specific situation.
Not every patient who reaches Stage D will be suitable for an LVAD or a transplant. Advanced age, involvement of other organs, or an overall health condition can sometimes make major surgery too risky. In those situations, the focus shifts to palliative care — managing symptoms, maintaining quality of life, and supporting the patient and family with the same level of attention and compassion that any surgical pathway deserves.
But for patients who do have options, the biggest threat is waiting too long to use them.
Dr. Khullar regularly sees patients who arrive after months of worsening symptoms, multiple hospitalisations, and significant kidney damage caused by prolonged low cardiac output. By the time they reach his clinic, some of those options have already closed.
Reaching Stage D heart failure is frightening for the patient and for the family. But it does not mean that nothing can be done. An LVAD or a heart transplant has given thousands of patients years of life they would not otherwise have had. What matters most is getting the right evaluation early enough that those options are still on the table. If you or someone you love is at this stage, the most important thing you can do right now is speak with a surgeon who has done this before, many times, and at the highest level.
Dr. Vishal Khullar brings over 30 years of experience and world-class transplant training to his practice in Mumbai. Early evaluation saves options. Request your appointment here.
In a small number of cases, yes. Conditions like myocarditis or peripartum cardiomyopathy can sometimes recover with mechanical support, and the LVAD can eventually be removed. But for most Stage D patients, recovery of the native heart is unlikely. The realistic goal is meaningful life extension and improved quality of life through an LVAD or transplant.
Many patients live three to five years or more, and that number continues to improve as device technology advances. Quality of life is often significantly better than before the device was implanted. For patients on destination therapy, the LVAD frequently enables years of active, fulfilling daily life.
Yes. Heart transplants are performed at select specialised centres in India. Dr. Vishal Khullar has performed transplant procedures in Mumbai and trained under some of the world’s leading programmes at Mayo Clinic and Cleveland Clinic in the United States.
This is a genuinely difficult question and one that deserves an honest answer. Some patients on LVAD as a bridge to transplant end up living with the device long term because a suitable donor heart does not become available in time. This is called destination therapy, and for many of these patients it provides years of active, meaningful life even without ever receiving a transplant.
WhatsApp us

